Xianmei Meng
- Neurology top 10%
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 4
- Developmental Neuroscience top 10%
-
- Pluripotent Stem Cells Research 4
- Congenital heart defects research 3
-
- Fullerene Chemistry and Applications 4
-
- Tissue Engineering and Regenerative Medicine 3
-
- Biomarkers in Disease Mechanisms 3
-
- Carbon Nanotubes in Composites 3
- Co-authors
- Li ZhangBo LiChiranjib DasguptaLei HuangK.‐H. William LauTong DangDaila S. GridleyDavid J. Baylink
- Journals
- Scientific Reports (3 papers)Biosensors and Bioelectronics (3 papers)Analytical Biochemistry (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xianmei Meng
45 papers receiving 960 citations
Peers
Comparison fields: 5 of 109
- Neurology 109
- Cancer Research 150
- Developmental Neuroscience 37
- Pediatrics, Perinatology and Child Health 164
- Molecular Biology 478
Countries citing papers authored by Xianmei Meng
This map shows the geographic impact of Xianmei Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianmei Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianmei Meng more than expected).
Fields of papers citing papers by Xianmei Meng
This network shows the impact of papers produced by Xianmei Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianmei Meng. The network helps show where Xianmei Meng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xianmei Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 11 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 0 | |
| 8 | 2020 | 3 | |
| 9 | 2020 | 17 | |
| 10 | 2019 | 126 | |
| 11 | 2018 | 13 | |
| 12 | 2016 | 1 | |
| 13 | 2013 | 1 | |
| 14 | 2013 | 65 | |
| 15 | 2013 | 7 | |
| 16 | 2013 | 33 | |
| 17 | 2012 | 20 | |
| 18 | 2011 | 74 | |
| 19 | 2007 | 5 | |
| 20 | 2007 | 20 |
About Xianmei Meng
Xianmei Meng is a scholar working on Virology, Gastroenterology and Cancer Research, having authored 49 papers that have together received 977 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers), Pluripotent Stem Cells Research (4 papers), Fullerene Chemistry and Applications (4 papers), Tissue Engineering and Regenerative Medicine (3 papers), Biomarkers in Disease Mechanisms (3 papers), Congenital heart defects research (3 papers) and Carbon Nanotubes in Composites (3 papers). The work is most often cited by research in Neurology (109 citations), Cancer Research (150 citations) and Developmental Neuroscience (37 citations). Xianmei Meng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Li Zhang, Bo Li, Chiranjib Dasgupta, Bo Li, Lei Huang, K.‐H. William Lau, Tong Dang, Daila S. Gridley, David J. Baylink and Xiao‐Bing Zhang. Their work appears in journals such as Scientific Reports, Biosensors and Bioelectronics, Analytical Biochemistry, Molecular Therapy and Cancer Control.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.